BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19537322)

  • 1. Preservation of fertility in patients with cancer.
    Blumenfeld Z
    N Engl J Med; 2009 Jun; 360(25):2680-1; author reply 2682-3. PubMed ID: 19537322
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
    Imai A; Furui T
    J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility preservation during treatment is a growing issue for women.
    Rowan K
    J Natl Cancer Inst; 2010 Mar; 102(5):294-6. PubMed ID: 20173119
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
    Castelo-Branco C; Nomdedeu B; Camus A; Mercadal S; Martínez de Osaba MJ; Balasch J
    Fertil Steril; 2007 Mar; 87(3):702-5. PubMed ID: 17173900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are gonadotropin-releasing hormone analogs safe and effective for protection of ovarian reserve against chemotherapeutic insult?
    Sönmezer M; Taşçi T; Gözüküçük M
    Gynecol Endocrinol; 2008 Feb; 24(2):64-5; author reply 66. PubMed ID: 18210327
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary: Ovarian function does not equal fertility does not equal babies.
    Moore HC; Theriault RL
    Oncologist; 2007 Sep; 12(9):1067-9. PubMed ID: 17914076
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy-induced gonadotoxicity.
    Wang PH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):1-2. PubMed ID: 20466285
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury.
    Oktay K; Sönmezer M; Oktem O; Fox K; Emons G; Bang H
    Oncologist; 2007 Sep; 12(9):1055-66. PubMed ID: 17914075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An individualized approach to fertility preservation in women with cancer.
    Oktay K
    J Support Oncol; 2006 Apr; 4(4):181-2, 184. PubMed ID: 16669460
    [No Abstract]   [Full Text] [Related]  

  • 10. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
    Blumenfeld Z
    Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial role of gonadotropin releasing hormone agonists on fertility preservation.
    Blumenfeld Z
    Pediatr Blood Cancer; 2009 Dec; 53(6):1159; author reply 1160. PubMed ID: 19484751
    [No Abstract]   [Full Text] [Related]  

  • 12. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
    Blumenfeld Z; von Wolff M
    Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation in female oncology patients.
    Stern CJ; Toledo MG; Gook DA; Seymour JF
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):15-23. PubMed ID: 16441687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
    Sinha R; Dionne JM
    Arch Dis Child; 2008 May; 93(5):444-5. PubMed ID: 17908713
    [No Abstract]   [Full Text] [Related]  

  • 15. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
    Peccatori F; Demeestere I
    Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation.
    von Wolff M; Donnez J; Hovatta O; Keros V; Maltaris T; Montag M; Salle B; Sonmezer M; Andersen CY
    Eur J Cancer; 2009 Jun; 45(9):1547-53. PubMed ID: 19264478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do GnRH analogs protect against ovarian toxicity of chemotherapy?
    Moore HC
    Breast Cancer Res Treat; 2009 Oct; 117(3):569-70. PubMed ID: 19234783
    [No Abstract]   [Full Text] [Related]  

  • 18. Preservation of fertility in patients with cancer.
    Meirow D; Wallace WH
    N Engl J Med; 2009 Jun; 360(25):2682; author reply 2682-3. PubMed ID: 19537325
    [No Abstract]   [Full Text] [Related]  

  • 19. Review. Fertility preservation for young female cancer patients.
    Maltaris T; Beckmann MW; Dittrich R
    In Vivo; 2009; 23(1):123-30. PubMed ID: 19368136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Techniques for fertility preservation in patients with breast cancer.
    Dunn L; Fox KR
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.